|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues (exclusive of depreciation and amortization shown below) | |||||
| Selling, general and administrative expense | |||||
| Fair value changes in business acquisition contingencies | |||||
| Depreciation and amortization | |||||
| Income (loss) from operations | |||||
| Other income (expense), net | |||||
| Interest expense, net | |||||
| Total other expense, net | |||||
| Income (loss) before expense from income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Convertible and redeemable Series A-2 Preferred Stock dividend | |||||
| Net income (loss) attributable to common stockholders | |||||
| Equity adjustment from foreign currency translation | |||||
| Comprehensive income (loss) | |||||
| Weighted average common shares outstanding - basic | |||||
| Weighted average common shares outstanding - diluted | |||||
| Net income (loss) per share attributable to common stockholders - basic | |||||
| Net income (loss) per share attributable to common stockholders - diluted | |||||
Loading...